Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
5
(6 Reviews)
|
(24 Publications)
Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (ab201061) is a rabbit monoclonal antibody detecting beta Amyloid 1-42 in IHC-P, Dot Blot. Suitable for Human, Mouse.
- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications
View Alternative Names
A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (AB201061)
IHC image of beta Amyloid 1-42 staining in human Alzheimer hippocampus formalin fixed paraffin embedded tissue section*, performed on a Leica Bond™ system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab201061, 1μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- Dot
Supplier Data
Dot Blot - Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (AB201061)
Dot blot analysis of beta Amyloid 1-42 labeled with ab201061 at 1/10000 dilution.
Lane 1 : beta Amyloid (Aβ) 1-40.
Lane 2 : beta Amyloid (Aβ) 1-42.
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/5000 dilution was used as secondary antibody.
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 30 seconds.
Antibody reactivity was assessed using a dot blot, which is a non-quantitative method that maintains the native conformation of beta Amyloid. Beta Amyloid 1-40 and 1-42 peptides underwent the following aggregation conditions before being spotted onto a nitrocellulose membrane and detected using ab201061 :
Monomers : 0.3 mg of beta Amyloid peptide was dissolved in 30 μl 100 mM NaOH and incubated at room temperature for 10 minutes. It was then diluted with 970 μl of 1% SDS and boiled for five minutes.
Oligomers : 0.3 mg of beta Amyloid peptide was dissolved in 30 μl 100 mM NaOH and incubated at room temperature for 10 minutes. It was then diluted with 970 μl of 10 mM phosphate buffer pH 7.4 containing 0.02% sodium azide and incubated at room temperature for four days.
Fibrils : 0.3 mg of beta Amyloid peptide was dissolved in 1 ml 50% hexafluoroisopropanol (HFIP) with 0.02% sodium azide. It was then stirred constantly for nine days; the first seven with a cap on and the final two with the cap removed to allow evaporation of the HFIP. Fibrils were then sedimented at 20,000 rpm in a microcentrifuge for 20 minutes and resuspended in 1 ml of PBS + 0.02% sodium azide.
- Dot
Supplier Data
Dot Blot - Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (AB201061)
Negative control (secondary ab only) :
Lane 1 : beta Amyloid (Aβ) 1-40.
Lane 2 : beta Amyloid (Aβ) 1-42.
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1/5000 dilution was used as secondary antibody.
Blocking and diluting buffer : 5% NFDM/TBST.
Exposure time : 30 seconds.
Related conjugates and formulations (1)
-
Anti-beta Amyloid 1-42 antibody [mOC98] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-beta Amyloid 1-42 antibody [mOC98] - Conformation-Specific (ab201061) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P), Dot Blot in Human, Mouse samples.
Trusted by the scientific community
Anti-beta Amyloid 1-42 [mOC98] - Conformation-Specific (ab201061) was first used in a scientific publication in 2015 and has been cited over 10 times in peer-reviewed journals.
Reviewed by scientists
Anti-beta Amyloid 1-42 [mOC98] - Conformation-Specific (ab201061) has over 5 independent reviews from customers.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [mOC98] also available for your convenience: ab201061, Carrier free - ab240360
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Amyloid beta 1-42 plays a central role in synaptic activity and neuronal health. While not inherently pathogenic its tendency to aggregate forms oligomers and fibrils which become toxic to neurons. This peptide contributes to synaptic dysfunction and neuronal cell death and is a major component of extracellular amyloid plaques found in brain tissue. Within the cellular environment amyloid beta 1-42 can interact with receptors membrane lipids and intracellular signaling mechanisms thereby affecting neuronal cell function.
Pathways
Amyloid beta 1-42 is important in the amyloidogenic pathway which is one of the critical components in APP processing. The pathway includes proteolytic enzymes like beta secretase (BACE1) and gamma secretase where misregulation may lead to excessive production or deposition of amyloid beta peptides. Another related pathway is the tau protein phosphorylation pathway which indirectly interacts with amyloid beta 1-42 due to shared signaling intermediates impacting tau stabilization and microtubule assembly in neurons.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (24)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:5948 PubMed40592843
2025
Applications
Unspecified application
Species
Unspecified reactive species
Glia 73:1258-1271 PubMed40009021
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 23:7 PubMed39762888
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 21:263 PubMed39425119
2024
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 12: PubMed39200168
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging and disease 15:2752-2769 PubMed38502590
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in aging neuroscience 15:1250342 PubMed37810621
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in aging neuroscience 15:1212212 PubMed37547743
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in neurology 14:1183764 PubMed37441611
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 21:91 PubMed37143104
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com